Glutamate ionotropic receptor NMDA type subunit 2B and Excitatory amino acid transporters (GluN2B and EAATs)

The target "Glutamate transporters and NMDA receptor GluN2B" refers to a functional signaling axis in the central nervous system that regulates excitatory neurotransmission and glutamate homeostasis [1, 6]. Excitatory amino acid transporters (EAATs), such as EAAT2 (GLT-1), are responsible for the rapid clearance of glutamate from the synaptic cleft into astrocytes to prevent neurotoxicity [6, 9]. The GluN2B subunit of the NMDA receptor (encoded by GRIN2B) is a key component of ionotropic glutamate receptors, particularly those located extrasynaptically, which are heavily implicated in excitotoxicity and neuronal death when overactivated by excess glutamate [2, 3, 5]. Dysregulation of this system, characterized by reduced glutamate uptake and overactivation of GluN2B-containing receptors, is a hallmark of neurodegenerative diseases like Alzheimer's and acute injuries such as stroke [5, 6, 12]. Pharmacological intervention typically aims to either enhance transporter function to lower extracellular glutamate or selectively antagonize GluN2B subunits to prevent neuronal death while sparing normal synaptic transmission [5, 10, 12]. This dual-target approach is also highly relevant in psychiatry, where GluN2B modulators like ketamine and ifenprodil show promise for treating major depressive disorder by restoring synaptic plasticity [5, 9, 10]. Overall, this target system is central to maintaining the balance between healthy synaptic communication and pathological neurodegeneration [6, 12]. Therapeutic challenges include avoiding the psychotomimetic and dissociative side effects often associated with broad NMDA receptor antagonism [5, 12].

Other names

NR2BNMDAR2BGRIN2BGlutamate transportersExcitatory amino acid transportersEAATsSLC1A familyGlutamate receptor ionotropic NMDA 2B

Negative allosteric modulation of GluN2B-containing NMDA receptors; Enhancement of glutamate transporter expression and activity; Inhibition of glutamate release.